📰 Lead Author News
Page 47 - Lead Author News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lead Author. Real-time updates on events, politics, business and more.
May 1, 2022
Solidaire Congratulates Prof Nana Ama Browne Klutse
April 30, 2022
Solidaire Congratulates Prof Nana Ama Browne Klutse
April 27, 2022
Mount Sinai researchers have discovered a previously unknown mechanism in which not-yet-malignant cells from early breast cancer tumors travel to other organs and, eventually, "turn on" and become metastatic breast cancer.
April 26, 2022
Pioneering research has shed new light on what drives people's basic food preferences, indicating our choices may be smarter than previously thought and influenced by the specific nutrients, as opposed to just calories, we need.
April 26, 2022
Feelings of anxiety and depression are common in people living with dementia and mild cognitive impairment, but the best way to treat these symptoms is currently unknown, as medicines often used to treat these symptoms may not be effective for people with dementia and may cause side effects.
April 14, 2022
Diverse microbial life existed on Earth at least 3.75 billion years ago, suggests a new study led by UCL researchers that challenges the conventional view of when life began.
April 14, 2022
Patients that have suffered a stroke could receive critical early treatment in the crucial window shortly after experiencing an attack. This is thanks to a joystick-based system developed by MIT researchers that would give surgeons remote access to patients.
April 12, 2022
People who are organized, with high levels of self-discipline, may be less likely to develop mild cognitive impairment as they age, while people who are moody or emotionally unstable are more likely to experience cognitive decline late in life, according to research published by the American Psychological Association.
April 11, 2022
The rare blood clot side-effect associated with some COVID-19 vaccines could be the result of genetics, new research has found, paving the way for a potential genetic screening test.
April 6, 2022
Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them.